NASDAQ : CV
CapsoVision, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 6.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 347.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 336.82M |
| Enterprise Value | 328.43M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 50.05M |
| Shares Outstanding | 50.05M |
| Shares Change (YoY) | +2,118.22% |
| Shares Change (QoQ) | +5.23% |
| Owned by Insiders (%) | 37.20% |
| Owned by Institutions (%) | 10.43% |
| Float | 27.98M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.25 |
| Forward PS | 19.90 |
| PB Ratio | 25.57 |
| P/TBV Ratio | 25.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 23.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.35 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -335.06% |
| Return on Assets (ROA) | -132.47% |
| Return on Invested Capital (ROIC) | -181.18% |
| Return on Capital Employed (ROCE) | -222.18% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $140,313 |
| Profits Per Employee | -$301,303 |
| Employee Count | 99 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 1.59 |
Taxes
| Measure | Value |
|---|
| Income Tax | 24,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | +37.91% |
| 50-Day Moving Average | 6.44 |
| 200-Day Moving Average | 6.36 |
| Relative Strength Index (RSI) | 51.28 |
| Average Volume (20 Days) | 119,999 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.18M |
| Short Previous Month | 2.10M |
| Short % of Shares Out | 4.36% |
| Short % of Float | 7.80% |
| Short Ratio (days to cover) | 8.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 13.89M |
| Gross Profit | 7.07M |
| Operating Income | -29.80M |
| Pretax Income | -29.81M |
| Net Income | -29.83M |
| EBITDA | -29.57M |
| EBIT | -29.80M |
| Loss Per Share | -$0.62 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.08M |
| Total Debt | 687,000 |
| Net Cash | 8.39M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 13.17M |
| Book Value Per Share | 0.26 |
| Working Capital | 12.12M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -27.82M |
| Capital Expenditures | -68,000 |
| Depreciation & Amortization | 223,000 |
| Net Borrowing | -1.00M |
| Free Cash Flow | -27.89M |
| FCF Per Share | -$0.56 |
Margins
| Measure | Value |
|---|
| Gross Margin | 50.88% |
| Operating Margin | -214.51% |
| Pretax Margin | -214.56% |
| Profit Margin | -214.74% |
| EBITDA Margin | -212.90% |
| EBIT Margin | -214.51% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2,118.22% |
| Shareholder Yield | -2,118.22% |
| Earnings Yield | -9.27% |
| FCF Yield | -8.28% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $9.50 |
| Price Target Difference | 41.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 44.62% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 12.71 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |